Literature DB >> 3698263

Erythrocyte aldehyde dehydrogenase: assay of a potential biochemical marker of alcohol abuse.

J F Towell, J J Barboriak, W F Townsend, J H Kalbfleisch, R I Wang.   

Abstract

Erythrocyte aldehyde dehydrogenase (ALDH; EC 1.2.1.3) may be a new biochemical indicator of alcohol abuse. An improved assay for it is described and characterized. We found that expression of erythrocyte ALDH activity in terms of hemoglobin was valid, and preferable to expression in terms of erythrocyte volume. A normal reference interval was determined from results for 375 healthy subjects (236 men, 139 women). We compared these data with results for 109 men admitted to our alcohol detoxification program. The mean erythrocyte ALDH of the alcohol abusers was 30% lower than our mean value for men (p less than 0.001). Values did not change between the time the patient presented for admission and greater than 48 h later (when blood-ethanol concentration was zero). Other variables that affect erythrocyte ALDH activities--changes in pH, temperature, other assay conditions, and drug treatments such as disulfiram and nitrate anti-anginals--are discussed.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3698263

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  2 in total

1.  Erythrocyte aldehyde dehydrogenase = a potential marker for alcohol dependence.

Authors:  P Murthy; S C Guru; S M Channabasavanna; D K Subbakrishna; T Shetty
Journal:  Indian J Psychiatry       Date:  1996-01       Impact factor: 1.759

2.  Impact of chronic congestive heart failure on pharmacokinetics and vasomotor effects of infused nitrite.

Authors:  Abdul R Maher; Sayqa Arif; Melanie Madhani; Khalid Abozguia; Ibrar Ahmed; Bernadette O Fernandez; Martin Feelisch; A G O'Sullivan; Arthur Christopoulos; Aaron L Sverdlov; Doan Ngo; Rustem Dautov; Philip E James; John D Horowitz; Michael P Frenneaux
Journal:  Br J Pharmacol       Date:  2013-06       Impact factor: 8.739

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.